Efficacy and safety of the cladribine, idarubicin, and cytarabine regimen for treating acute myeloid leukemia: a systematic review and single-arm meta-analysis.
- DOI
- 10.1007/s40199-026-00692-0
- Published
- 2026 Nov 9
- Container
- Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40199-026-00692-0,
title = {Efficacy and safety of the cladribine, idarubicin, and cytarabine regimen for treating acute myeloid leukemia: a systematic review and single-arm meta-analysis.},
author = {Xu Y and Chen S and Zhang R},
year = {2026},
journal = {Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences},
doi = {10.1007/s40199-026-00692-0},
url = {https://doi.org/10.1007/s40199-026-00692-0}
}RIS
TY - JOUR TI - Efficacy and safety of the cladribine, idarubicin, and cytarabine regimen for treating acute myeloid leukemia: a systematic review and single-arm meta-analysis. AU - Xu Y AU - Chen S AU - Zhang R PY - 2026 JO - Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences DO - 10.1007/s40199-026-00692-0 UR - https://doi.org/10.1007/s40199-026-00692-0 ER -
APA
Y, X., S, C., & R, Z. (2026). Efficacy and safety of the cladribine, idarubicin, and cytarabine regimen for treating acute myeloid leukemia: a systematic review and single-arm meta-analysis.. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences. https://doi.org/10.1007/s40199-026-00692-0
Source records
- pubmed · retrieved 2026-11-10T10:13:43.884Z